Semler Scientific, Inc. (SMLR)
USD 33.51
(-1.63%)
USD 33.51
(-1.63%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 61.2 Million USD | 16.72% |
| 2022 | 52.43 Million USD | 11.79% |
| 2021 | 46.9 Million USD | 33.08% |
| 2020 | 35.24 Million USD | 21.1% |
| 2019 | 29.1 Million USD | 54.92% |
| 2018 | 18.78 Million USD | 89.8% |
| 2017 | 9.89 Million USD | 78.01% |
| 2016 | 5.56 Million USD | 33.87% |
| 2015 | 4.15 Million USD | 41.15% |
| 2014 | 2.94 Million USD | 63.05% |
| 2013 | 1.8 Million USD | 116.17% |
| 2012 | 835 Thousand USD | 388.3% |
| 2011 | 171 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 14.65 Million USD | 25.57% |
| 2024 Q3 | 12.35 Million USD | -6.46% |
| 2024 Q2 | 13.21 Million USD | -9.87% |
| 2023 Q2 | 17.38 Million USD | 2.65% |
| 2023 Q1 | 16.93 Million USD | 34.29% |
| 2023 FY | 61.2 Million USD | 16.72% |
| 2023 Q4 | 11.67 Million USD | -23.24% |
| 2023 Q3 | 15.2 Million USD | -12.54% |
| 2022 Q3 | 12.9 Million USD | -6.9% |
| 2022 Q4 | 12.61 Million USD | -2.3% |
| 2022 Q1 | 13.04 Million USD | 39.13% |
| 2022 FY | 52.43 Million USD | 11.79% |
| 2022 Q2 | 13.86 Million USD | 6.28% |
| 2021 Q1 | 11.6 Million USD | 4.66% |
| 2021 Q4 | 9.37 Million USD | -25.63% |
| 2021 Q2 | 13.31 Million USD | 14.74% |
| 2021 FY | 46.9 Million USD | 33.08% |
| 2021 Q3 | 12.6 Million USD | -5.3% |
| 2020 Q1 | 8.58 Million USD | 4.06% |
| 2020 Q2 | 5.67 Million USD | -33.88% |
| 2020 Q4 | 11.08 Million USD | 11.91% |
| 2020 FY | 35.24 Million USD | 21.1% |
| 2020 Q3 | 9.9 Million USD | 74.63% |
| 2019 Q3 | 7.92 Million USD | 12.17% |
| 2019 Q2 | 7.06 Million USD | 20.51% |
| 2019 Q4 | 8.24 Million USD | 4.0% |
| 2019 Q1 | 5.86 Million USD | 11.5% |
| 2019 FY | 29.1 Million USD | 54.92% |
| 2018 FY | 18.78 Million USD | 89.8% |
| 2018 Q4 | 5.26 Million USD | 5.96% |
| 2018 Q3 | 4.96 Million USD | 3.33% |
| 2018 Q2 | 4.8 Million USD | 27.8% |
| 2018 Q1 | 3.75 Million USD | 6.94% |
| 2017 Q1 | 1.51 Million USD | -15.41% |
| 2017 Q2 | 1.98 Million USD | 31.09% |
| 2017 Q3 | 2.88 Million USD | 45.17% |
| 2017 Q4 | 3.51 Million USD | 21.92% |
| 2017 FY | 9.89 Million USD | 78.01% |
| 2016 Q1 | 1.08 Million USD | 11.29% |
| 2016 FY | 5.56 Million USD | 33.87% |
| 2016 Q4 | 1.79 Million USD | 13.07% |
| 2016 Q3 | 1.58 Million USD | 43.61% |
| 2016 Q2 | 1.1 Million USD | 1.75% |
| 2015 Q4 | 974 Thousand USD | -17.25% |
| 2015 Q3 | 1.17 Million USD | 11.14% |
| 2015 FY | 4.15 Million USD | 41.15% |
| 2015 Q2 | 1.05 Million USD | 7.84% |
| 2015 Q1 | 982 Thousand USD | 13.26% |
| 2014 Q1 | 682 Thousand USD | 15.99% |
| 2014 Q3 | 719 Thousand USD | 6.68% |
| 2014 Q4 | 867 Thousand USD | 20.58% |
| 2014 FY | 2.94 Million USD | 63.05% |
| 2014 Q2 | 674 Thousand USD | -1.17% |
| 2013 Q4 | 588 Thousand USD | 28.95% |
| 2013 Q1 | 343 Thousand USD | 16.27% |
| 2013 FY | 1.8 Million USD | 116.17% |
| 2013 Q2 | 418 Thousand USD | 21.87% |
| 2013 Q3 | 456 Thousand USD | 9.09% |
| 2012 Q3 | 249 Thousand USD | 0.0% |
| 2012 Q4 | 295 Thousand USD | 18.47% |
| 2012 FY | 835 Thousand USD | 388.3% |
| 2011 FY | 171 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 2.55 Million USD | -2300.0% |
| BrainsWay Ltd. | 23.09 Million USD | -165.038% |
| Cerus Corporation | 86.4 Million USD | 29.167% |
| Envoy Medical, Inc. | -473 Thousand USD | 13038.689% |
| electroCore, Inc. | 13.22 Million USD | -362.725% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | -100227.869% |
| IceCure Medical Ltd | 1.3 Million USD | -4607.692% |
| Inogen, Inc. | 126.69 Million USD | 51.697% |
| OrthoPediatrics Corp. | 111.25 Million USD | 44.99% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 1111.57% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 129388.491% |
| MaxCyte, Inc. | 36.54 Million USD | -67.46% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | -13305.853% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -71849.212% |
| Orthofix Medical Inc. | 486.27 Million USD | 87.414% |
| PAVmed Inc | -3.96 Million USD | 1642.339% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 1215.77% |
| RxSight, Inc. | 53.76 Million USD | -13.829% |
| Sight Sciences, Inc. | 69.17 Million USD | 11.529% |
| SI-BONE, Inc. | 109.42 Million USD | 44.069% |
| TELA Bio, Inc. | 40.11 Million USD | -52.573% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | 59.72% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | -639.935% |
| Acutus Medical, Inc. | -3.13 Million USD | 2050.909% |
| Talis Biomedical Corporation | 371 Thousand USD | -16395.957% |
| Spectral AI, Inc. | 7.88 Million USD | -676.65% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 1028.398% |
| CVRx, Inc. | 33.03 Million USD | -85.236% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | -8175.571% |
| Bioventus Inc. | 328.19 Million USD | 81.352% |
| Venus Concept Inc. | 52.16 Million USD | -17.316% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | -284.76% |
| LivaNova PLC | 771.25 Million USD | 92.065% |
| 908 Devices Inc. | 25.32 Million USD | -141.687% |
| Alphatec Holdings, Inc. | 310.2 Million USD | 80.271% |
| Nemaura Medical Inc. | -1.47 Million USD | 4245.241% |
| NeuroPace, Inc. | 48.12 Million USD | -27.177% |
| LENSAR, Inc. | 21.1 Million USD | -189.951% |
| Apyx Medical Corporation | 14.12 Million USD | -333.366% |
| Cutera, Inc. | 41.49 Million USD | -47.491% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | -231.51% |
| BioSig Technologies, Inc. | 18 Thousand USD | -339900.0% |
| Anika Therapeutics, Inc. | 103.08 Million USD | 40.633% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | -349.537% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | 93.111% |
| Axonics, Inc. | 274.55 Million USD | 77.709% |
| Outset Medical, Inc. | 29 Million USD | -111.034% |
| IRIDEX Corporation | 21.8 Million USD | -180.644% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | 13.862% |
| IRadimed Corporation | 50.15 Million USD | -22.014% |
| Tivic Health Systems, Inc. | 287 Thousand USD | -21224.042% |
| INVO Bioscience, Inc. | 1.08 Million USD | -5534.643% |
| Telesis Bio, Inc. | 16.95 Million USD | -261.062% |
| Viemed Healthcare, Inc. | 112.78 Million USD | 45.737% |
| Varex Imaging Corporation | 256.9 Million USD | 76.178% |
| Quipt Home Medical Corp. | 163.84 Million USD | 62.648% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 15173.892% |
| Pulmonx Corporation | 50.75 Million USD | -20.586% |
| Dynatronics Corporation | 7.63 Million USD | -701.574% |
| Modular Medical, Inc. | -768 Thousand USD | 8068.75% |
| ReShape Lifesciences Inc. | 5.54 Million USD | -1003.1% |
| InMode Ltd. | 411.34 Million USD | 85.122% |
| Bruker Corporation | 1.51 Billion USD | 95.965% |
| Cytosorbents Corporation | 22.39 Million USD | -173.312% |
| DexCom, Inc. | 2.28 Billion USD | 97.326% |
| Align Technology, Inc. | 2.71 Billion USD | 97.749% |
| Viveve Medical, Inc. | 620 Thousand USD | -9770.968% |
| ZimVie Inc. | 290.38 Million USD | 78.924% |
| Movano Inc. | -158 Thousand USD | 38834.177% |
| Cytek Biosciences, Inc. | 109.42 Million USD | 44.072% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -71849.212% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | 83.356% |
| Profound Medical Corp. | 4.51 Million USD | -1255.776% |
| Insulet Corporation | 1.15 Billion USD | 94.724% |
| enVVeno Medical Corporation | -546 Thousand USD | 11308.791% |
| Surmodics, Inc. | 93.05 Million USD | 34.23% |
| iCAD, Inc. | 14.53 Million USD | -321.024% |
| Nuwellis, Inc. | 4.98 Million USD | -1128.176% |
| Biotricity, Inc. | 8.35 Million USD | -632.383% |
| iRhythm Technologies, Inc. | 331.8 Million USD | 81.555% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 17144.648% |
| InspireMD, Inc. | 1.8 Million USD | -3286.829% |
| PAVmed Inc. | -3.96 Million USD | 1642.339% |
| BIOLASE, Inc. | 16.72 Million USD | -265.941% |
| Beyond Air, Inc. | -1.3 Million USD | 4782.479% |
| FONAR Corporation | 45.14 Million USD | -35.578% |
| AxoGen, Inc. | 127.87 Million USD | 52.14% |
| Vivani Medical, Inc. | -357 Thousand USD | 17242.857% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | 68.637% |
| Inari Medical, Inc. | 434.56 Million USD | 85.917% |
| UFP Technologies, Inc. | 112.22 Million USD | 45.467% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -488756.937% |
| Tenon Medical, Inc. | 1.24 Million USD | -4831.507% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 75655.556% |
| Co-Diagnostics, Inc. | 2.62 Million USD | -2229.575% |
| AdaptHealth Corp. | 479.56 Million USD | 87.238% |
| Sintx Technologies, Inc. | 1.84 Million USD | -3220.673% |
| NanoVibronix, Inc. | 1.53 Million USD | -3881.783% |
| Quanterix Corporation | 70.64 Million USD | 13.371% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 15173.892% |
| Sensus Healthcare, Inc. | 14.06 Million USD | -335.277% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | -15.953% |
| TransMedics Group, Inc. | 154.09 Million USD | 60.284% |
| ReWalk Robotics Ltd. | 4.45 Million USD | -1274.354% |
| NeuroMetrix, Inc. | 3.94 Million USD | -1450.382% |
| Hyperfine, Inc. | 4.75 Million USD | -1186.525% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | 42.791% |
| Biomerica, Inc. | 611 Thousand USD | -9916.367% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | -46.807% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 7936.559% |
| Silk Road Medical, Inc | 127.08 Million USD | 51.844% |